Literature DB >> 11061078

Acute lymphoblastic leukemia in one of two siblings with Alstrom syndrome.

B H Chen1, S S Chiou, R K Tsai, Y F Lin, J R Wu.   

Abstract

Alstrom syndrome is a rare autosomal recessive disease; less than 60 cases have been reported. No Chinese patient with this disease has been reported previously in the literature. Here, we describe an 11-year-old Chinese boy with this condition. His elder sister also had Alstrom syndrome, and his father had non-insulin-dependent diabetes mellitus. Both siblings had degenerative retinopathy, obesity, mental retardation, perceptive hearing loss, short stature, non-insulin-dependent diabetes mellitus, nephropathy, hyperlipidemia, acanthosis nigricans, and hepatic dysfunction. The boy also developed acute lymphoblastic leukemia, which was confirmed by cytochemistry and immunophenotyping findings. He received chemotherapy and radiotherapy for the malignancy. The present case suggests that acute lymphoblastic leukemia may be coincident with or may be a previously undescribed systemic manifestation of Alstrom syndrome.

Entities:  

Mesh:

Year:  2000        PMID: 11061078

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  3 in total

1.  Follicular variant of papillary thyroid cancer in Alström syndrome.

Authors:  M Papadakis; A Meyer; F Schuster; N Weyerbrock; C Corinth; C Dotzenrath
Journal:  Fam Cancer       Date:  2015-12       Impact factor: 2.375

2.  Alström syndrome with a novel mutation of ALMS1 and Graves' hyperthyroidism: A case report and review of the literature.

Authors:  Juan-Juan Zhang; Jun-Qi Wang; Man-Qing Sun; Yuan Xiao; Wen-Li Lu; Zhi-Ya Dong
Journal:  World J Clin Cases       Date:  2021-05-06       Impact factor: 1.337

Review 3.  Alstrom syndrome (OMIM 203800): a case report and literature review.

Authors:  Tisha Joy; Henian Cao; Graeme Black; Rayaz Malik; Valentine Charlton-Menys; Robert A Hegele; Paul N Durrington
Journal:  Orphanet J Rare Dis       Date:  2007-12-21       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.